A staggering £48 million of public funds has been spent on an outsourced firm assessing vaccine-related injuries, sparking concerns and raising questions about the process. This amount, revealed by the BBC, is eight times the initial estimate and exceeds the compensation awarded to those affected by Covid vaccines.
The contract, initially valued at £6 million, was awarded to Crawford & Company Adjusters, but with over a year remaining, a new company will take over. The high costs are attributed to the unexpected volume of claims, with over 22,000 filed so far, mostly related to the AstraZeneca vaccine. However, only 1% of these claims have resulted in compensation, highlighting a potential disparity.
The Vaccine Damage Payment Scheme (VDPS), which handles these claims, has been under scrutiny. A law professor questioned the contract's nature, suggesting it should have been shorter and capped due to the uncertainty at the time. The NHS, in response, acknowledged the complexity and variability of public sector contracting processes.
But here's where it gets controversial: with such a high volume of claims, why has the compensation rate been so low? And why did it take so long for the NHS to address the spiraling costs? These questions remain unanswered, leaving room for speculation and debate.
What are your thoughts on this matter? Do you think the process could have been more efficient, or is this a necessary cost of ensuring vaccine safety? We'd love to hear your opinions in the comments below!
